ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Condition : By Disease Heading : Heart and Blood Vessel Diseases : Hypertension


Include trials that are no longer recruiting patients.

55 studies were found. Here are studies 1 to 50.
1.RecruitingPhase III Randomized Study of UT-15 in Patients with Primary Pulmonary Hypertension
Condition: Pulmonary Hypertension
2.RecruitingA Study to Evaluate the Safety and Pilot Efficacy of Iloprost Inhaled Solution as Add-On Therapy with Bosentan in Subjects with Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension; PAH; Pulmonary Hypertension
3.RecruitingA Transition Study From Flolan® to Remodulin® in Patients with Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension; Pulmonary Hypertension
4.RecruitingStudy of Inhaled Nitric Oxide for Preterm Infants
Conditions: Respiratory Distress Syndrome; Infant, Premature; Sepsis; Pneumonia; Hypertension, Pulmonary
5.RecruitingEfficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II
Condition: Pulmonary Hypertension
6.RecruitingARIES - Ambrisentan in Patients with Moderate to Severe Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Hypertension
7.RecruitingInhaled Nitric Oxide and Transfusion Therapy for Patients with Sickle Cell Anemia and Secondary Pulmonary Hypertension
Conditions: Sickle Cell Anemia; Pulmonary Hypertension
8.RecruitingSecondary Pulmonary Hypertension in Adults with Sickle Cell Anemia
Conditions: Pulmonary Hypertension; Sickle Cell Anemia
9.RecruitingSecondary Prevention of Small Subcortical Strokes (SPS3) Trial
Conditions: Cerebrovascular Accident; Hypertension
10.RecruitingMethods for Measuring Insulin Sensitivity
Conditions: Obesity; Hypertension; Diabetes-Mellitus, Non-Insulin Dependent
11.RecruitingSystolic Pressure Efficacy and Safety Trial of Alagebrium (SPECTRA)
Condition: Hypertension
12.RecruitingIrbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
Condition: Hypertension
13.RecruitingClevelox in the Postoperative Treatment of Hypertension
Condition: Hypertension
14.RecruitingClevelox in the Perioperative Treatment of Hypertension
Condition: Hypertension
15.RecruitingClevelox in the Preoperative Treatment of Hypertension
Condition: Hypertension
16.RecruitingStudy of Clevidipine Assessing its Postoperative Antihypertensive Effect in Cardiac Surgery
Condition: Hypertension
17.RecruitingStudy of Clevidipine Assessing its Preoperative Antihypertensive Effect in Cardiac Surgery
Condition: Hypertension
18.Not yet recruitingTreatment Effects on Platelet Calcium in Hypertensive and Depressed Patients
Conditions: Depression; Hypertension
19.RecruitingPhase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients
Conditions: Open-Angle Glaucoma; Ocular Hypertension
20.RecruitingPhase 4 study comparing IOP lowering in OAG or OH in Caucasian or Japanese subjects C-02-32
Conditions: Open-Angle Glaucoma; Ocular Hypertension
21.RecruitingPhase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes
Conditions: Open-Angle Glaucoma; Ocular Hypertension
22.RecruitingPhase 3 study to evaluate IOP lowering therapy in open angle glaucoma and ocular hypertension C-01-70
Conditions: Open-Angle Glaucoma; Ocular Hypertension
23.RecruitingPhase 3 study to evaluate IOP lowering therapy in open angle glaucoma and ocular hypertension C-02-41
Conditions: Open-Angle Glaucoma; Ocular Hypertension
24.RecruitingPhase 3 study to evaluate IOP lowering therapy in open angle glaucoma and ocular hypertension C-01-69
Conditions: Open-Angle Glaucoma; Ocular Hypertension
25.RecruitingSafety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients with Glaucoma or Ocular Hypertension.
Conditions: Glaucoma; Ocular Hypertension
26.RecruitingSafety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients with Glaucoma or Ocular Hypertension
Conditions: Glaucoma; Ocular Hypertension
27.RecruitingMechanism of Action of TRAVATAN 0.004% in Subjects with Glaucoma or Ocular Hypertension
Conditions: Glaucoma; Ocular Hypertension
28.Not yet recruitingCardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL)
Conditions: Atherosclerosis; Cardiovascular Diseases; Hypertension, Renovascular; Renal Artery Obstruction
29.RecruitingGenetic and Environmental Pathogenesis of PPH
Conditions: Lung Diseases; Hypertension, Pulmonary
30.RecruitingThe Effect of Tracleer™ on Male Fertility
Condition: Hypertension, Pulmonary
31.RecruitingDevelopment of a Hospital-Based Home Program for the Use of Inhaled Nitric Oxide in the Chronic Management of Severe Cardiopulmonary Diseases
Conditions: Pulmonary Hypertension; Lung Disease; Sickle Cell Disease; Cardiac transplant; Lung transplant
32.Not yet recruitingImpact of CPAP on Functional Outcomes in Milder Obstructive Sleep Apnea (CATNAP)
Conditions: Lung Diseases; Sleep Apnea Syndromes; Sleep; Hypertension
33.RecruitingImproving Medication Adherence in Comorbid Conditions
Conditions: Diabetes Mellitus, Type 2; Hypertension; Hyperlipidemia
34.RecruitingHypertension in Hemodialysis
Conditions: Hypertension; hemodialysis; Left Ventricular Hypertrophy
35.RecruitingACE Inhibition and Novel Cardiovascular Risk Factors
Conditions: Cardiovascular Diseases; Heart Diseases; Hypertension
36.Not yet recruitingMacronutrients and Cardiovascular Risk
Conditions: Cardiovascular Diseases; Heart Diseases; Atherosclerosis; Hypertension
37.RecruitingClinical Trial of Dietary Protein on Blood Pressure
Conditions: Cardiovascular Diseases; Hypertension; Heart Diseases
38.Not yet recruitingInsulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow
Condition: Hypertension
39.Not yet recruitingDose-Response to Exercise in Women Aged 45-75 Years
Conditions: Cardiovascular Diseases; Hypertension; Postmenopause
40.RecruitingJackson Heart Study (JHS)
Conditions: Cardiovascular Diseases; Heart Diseases; Atherosclerosis; Coronary Disease; Hypertension; Cerebrovascular Disorders
41.RecruitingSafety and Efficacy of Xenical in Children and Adolescents with Obesity-Related Diseases
Conditions: Diabetes Mellitus; Hypertension; Metabolic Disease; Obesity; Sleep Apnea Syndrome
42.RecruitingMetabolic Differences of Overweight Children and Children of Overweight Parents
Conditions: Cardiovascular Disease; Hypertension; Non Insulin Dependent Diabetes Mellitus; Obesity
43.RecruitingAction to Control Cardiovascular Risk in Diabetes (ACCORD)
Conditions: Atherosclerosis; Cardiovascular Diseases; Hypercholesterolemia; Hypertension; Diabetes Mellitus, non-insulin dependent; Diabetes Mellitus; ...
44.RecruitingA 6-week safety & efficacy study of combination intraocular pressure-lowering therapy in patients with open-angle glaucoma or ocular hypertension
Conditions: Glaucoma, Open-Angle; Ocular Hypertension
45.RecruitingA safety and efficacy study of Travoprost 0.004% compared to Latanoprost 0.005% in patients with chronic angle-closure glaucoma
Conditions: Glaucoma, Angle-Closure; Ocular Hypertension
46.RecruitingA long-term safety study of once-daily Travatan
Conditions: Glaucoma, Open-Angle; Ocular Hypertension
47.RecruitingA 6-week safety and efficacy study of Travatan compared to Xalcom in subjects with open-angle glaucoma(OAG) or ocular hypertension(OHT)
Conditions: Glaucoma, Open-Angle; Ocular Hypertension
48.RecruitingA safety and efficacy study of Travoprost 0.004% compared to Latanoprost 0.005% in patients with open-angle glaucoma(OAG) or ocular hypertension(OHT)
Conditions: Glaucoma, Open-Angle; Ocular Hypertension
49.RecruitingThe Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study
Conditions: Pseudotumor Cerebri; Cystinosis
50.RecruitingEstablishing the Physiology of Syringomyelia
Conditions: Arnold Chiari Deformity; Hydrocephalus; Syringomyelia

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act